Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura C Coates

Showing results (171-180 of 342) with videos related to

Pageof 35
Sort By:
Arthritis Care & Research|February 7, 2018
Minimal Disease Activity Among Active Psoriatic Arthritis Patients Treated With Secukinumab: 2-Year Results From a Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase III StudyLaura C Coates, Philip J Mease, Laure Gossec, et al.
Rheumatology (Oxford, England)|November 8, 2025
A retrospective observational study of effectiveness of sequential biologic and targeted synthetic DMARDs in psoriatic arthritis in the UKCharlotte E Gollins, Annie Russell, Theresa Smith, et al.
RMD Open|December 12, 2017
Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trialPhilip J Mease, Arthur Kavanaugh, Laura C Coates, et al.
Arthritis and Rheumatism|April 1, 2009
Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitisNick Barkham, Helen I Keen, Laura C Coates, et al.
The Journal of Rheumatology. Supplement|June 3, 2019
GRAPPA 2018 Project ReportNiti Goel, Oliver FitzGerald, Dafna D Gladman, et al.
Joint Bone Spine|March 27, 2021
A 12-point recommendation framework to support advancement of the multidisciplinary care of psoriatic arthritis: A call to actionJordi Gratacós, Frank Behrens, Laura C Coates, et al.
RMD Open|March 14, 2018
Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA)Philip J Mease, Dafna D Gladman, Ahmed S Samad, et al.
Clinical and Experimental Rheumatology|April 20, 2017
Reply to comment on: Clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trialAshok K Bhalla, Ashley S Bhalla, Laura C Coates, et al.
RMD Open|October 22, 2024
Digital biomarkers for psoriatic arthritis: a qualitative focus group study on patient-perceived opportunities and barriersPatty de Groot, Wendy Wagenaar, Jasper Foolen, et al.
Arthritis Care & Research|January 22, 2020
Comparing the Patient-Reported Physical Function Outcome Measures in a Real-Life International Cohort of Patients With Psoriatic ArthritisYing Ying Leung, Ana-Maria Orbai, Maarten de Wit, et al.
Pageof 35

Showing results (171-180 of 342) with videos related to

Sort By:
Pageof 35
Arthritis Care & Research|February 7, 2018
Minimal Disease Activity Among Active Psoriatic Arthritis Patients Treated With Secukinumab: 2-Year Results From a Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase III StudyLaura C Coates, Philip J Mease, Laure Gossec, et al.
Rheumatology (Oxford, England)|November 8, 2025
A retrospective observational study of effectiveness of sequential biologic and targeted synthetic DMARDs in psoriatic arthritis in the UKCharlotte E Gollins, Annie Russell, Theresa Smith, et al.
RMD Open|December 12, 2017
Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trialPhilip J Mease, Arthur Kavanaugh, Laura C Coates, et al.
Arthritis and Rheumatism|April 1, 2009
Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitisNick Barkham, Helen I Keen, Laura C Coates, et al.
The Journal of Rheumatology. Supplement|June 3, 2019
GRAPPA 2018 Project ReportNiti Goel, Oliver FitzGerald, Dafna D Gladman, et al.
Joint Bone Spine|March 27, 2021
A 12-point recommendation framework to support advancement of the multidisciplinary care of psoriatic arthritis: A call to actionJordi Gratacós, Frank Behrens, Laura C Coates, et al.
RMD Open|March 14, 2018
Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA)Philip J Mease, Dafna D Gladman, Ahmed S Samad, et al.
Clinical and Experimental Rheumatology|April 20, 2017
Reply to comment on: Clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trialAshok K Bhalla, Ashley S Bhalla, Laura C Coates, et al.
RMD Open|October 22, 2024
Digital biomarkers for psoriatic arthritis: a qualitative focus group study on patient-perceived opportunities and barriersPatty de Groot, Wendy Wagenaar, Jasper Foolen, et al.
Arthritis Care & Research|January 22, 2020
Comparing the Patient-Reported Physical Function Outcome Measures in a Real-Life International Cohort of Patients With Psoriatic ArthritisYing Ying Leung, Ana-Maria Orbai, Maarten de Wit, et al.
Pageof 35